resveratrol has been researched along with zerumbone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Koshimizu, K; Matsumoto, K; Murakami, A; Ohigashi, H | 1 |
Murakami, A | 1 |
Dash, B; Halder, M; Jha, S; Nandagopal, K; Nayak, S | 1 |
Akter, R; Bibi, P; Hassan, SSU; Mubin, S; Najda, A; Rahman, MH; Saeeda, S; Shah, M; WesoĊowska, S | 1 |
3 review(s) available for resveratrol and zerumbone
Article | Year |
---|---|
Chemoprevention with phytochemicals targeting inducible nitric oxide synthase.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Benzyl Alcohols; Catechin; Chemoprevention; Coumarins; Curcumin; Flavones; Mice; Nitric Oxide Synthase Type II; Rats; Resveratrol; Sesquiterpenes; Stilbenes | 2009 |
Biotechnological Approaches for Production of Anti-Cancerous Compounds Resveratrol, Podophyllotoxin and Zerumbone.
Topics: Animals; Antineoplastic Agents; Bacteria; Biotechnology; Cells, Cultured; Humans; Metabolic Engineering; Plants; Podophyllotoxin; Resveratrol; Sesquiterpenes | 2018 |
Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives.
Topics: Berberine; Biological Products; Curcumin; Emodin; Genistein; Humans; Neoplasms; Pentacyclic Triterpenes; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy; Resveratrol; Sesquiterpenes; Triterpenes; Ursolic Acid; Vitamin D; Withanolides | 2021 |
2 other study(ies) available for resveratrol and zerumbone
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW264.7 macrophages.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Benzyl Alcohols; Cell Line; Coumarins; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Induction; Enzyme Inhibitors; Flavones; Flavonoids; Food; Gene Expression Regulation; Genistein; I-kappa B Proteins; Interferon-gamma; Isoenzymes; Isothiocyanates; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Transcription Factor RelA | 2003 |